You are here

  • Home
  • Archive
  • Volume 82, Issue 2
  • Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Citation Tools

Article menu
Download PDFPDF
Myositis
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hosono Y, Sie B, Pinal-Fernandez I, et al
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies
Annals of the Rheumatic Diseases 2023;82:246-252.